Marimed Inc.

04/14/2025 | Press release | Distributed by Public on 04/14/2025 15:20

Initial Statement of Beneficial Ownership (Form 3)

FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5
(Print or Type Responses)
1. Name and Address of Reporting Person *
Crandall Ryan
2. Date of Event Requiring Statement (Month/Day/Year)
04/07/2025
3. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [MRMD]
(Last) (First) (Middle)
10 OCEANA WAY, 2ND FLOOR
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Commercial Officer
5. If Amendment, Date Original Filed (Month/Day/Year)
(Street)
NORWOOD, MA 02062
6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock, par value $.001 per share 598,002 D
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (RSU) (1) (1) Common Stock, par value $.001 per share 225,000 $0(2) D
Restricted Stock Units (RSU) (3) (3) Common Stock, par value $.001 per share 24,189 $0(2) D
Restricted Stock Units (RSU) (4) (4) Common Stock, par value $.001 per share 162,000 $0(2) D
Restricted Stock Units (RSU) (5) (5) Common Stock, par value $.001 per share 25,000 $0(2) D
Option to buy common stock (6) 12/23/2026 Common Stock, par value $.001 per share 1,000,000 $0.76 D
Option to buy common stock (6) 11/11/2025 Common Stock, par value $.001 per share 1,000,000 $0.25 D

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Crandall Ryan
10 OCEANA WAY, 2ND FLOOR
NORWOOD, MA 02062
Chief Commercial Officer

Signatures

/s/ Ryan Crandall 04/11/2025
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The RSUs vest over a three-year period as follows: (i) one-third on November 29, 2025; and (ii) in equal one-sixth installments every six months following November 29, 2025 through November 29, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
(2) RSUs convert to shares of common stock on a one-for-one basis.
(3) The RSUs vest in equal one-fourth installments every six months beginning on September 28, 2025 through March 28, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
(4) The RSUs vest in three equal installments of 54,000 shares of common stock on each of June 8, 2025, December 8, 2025 and June 8, 2026, respectively, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
(5) The RSUs vest in two equal installments of 12,500 shares of common stock on each of September 7, 2025 and March 7, 2026, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
(6) Immediately.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.